NCT06312709Completed
teleABLE to Reduce Post-Stroke Sedentary Behavior
teleABLE: Adapting a Behavioral Activation-Based Intervention to Reduce Post-Stroke Sedentary Behavior Using Telehealth (Pilot Randomized Controlled Trial)
Source: ClinicalTrials.gov · Last updated 10 Sept 2026
Brief summary (registry, in English)
The goal of this clinical trial to test whether a remotely delivered behavioral activation-based intervention called "teleABLE" works better than a health education intervention for (1) reducing sitting time and (2) improving health-related quality among adults who were diagnosed with stroke within the past 12 months. Participants in this study will: * Complete questionnaires at Weeks 1, 8, and 24 * Wear an activPAL monitor at Weeks 1, 8, and 24 * Participate in the teleABLE intervention (12 sessions) or the health education intervention (6 sessions) * Complete an interview at Week 24
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 90 (actual)
- First submitted
- 8 Mar 2024
- Start date
- 4 Apr 2024
- Primary completion date
- 28 Apr 2026
- Lead sponsor
- University of Minnesota
- Diseases
- Stroke
- NCT number
- NCT06312709
What you commit to
- Study type: Interventional
- Participants enrolled: 90
- From 4 Apr 2024 to the primary completion date, 28 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently receiving care in an inpatient rehabilitation, transitional care unit, or skilled nursing facility
- Received inpatient treatment or hospitalized for psychiatric condition and/or alcohol or substance abuse within the past 12 months
- Diagnosis of a terminal illness and/or currently receiving hospice care
- Concurrent participation in any other rehabilitation intervention research study (including cognitive and/or physical rehabilitation studies)
Other illness
- Comorbid neurodegenerative disorder (e.g. Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, myasthenia gravis, dementia, Alzheimer's disease, Huntington's disease, glioblastoma)
- Comorbid cancer, currently undergoing chemotherapy or radiation treatment
- Comorbid major depressive disorder (Patient Health Questionnaire-2, score ≥2)
- History of skin sensitivity that precludes the use of medical tape necessary for adherence to activity monitor measure
Other
- Severe cognitive or communication impairments (inability to respond accurately to complete study telephone screening or complete informed consent)
- Currently pregnant or expecting to become pregnant in the next 6 months
- Inability to speak, read, or understand English
- Investigator discretion for safety or adherence reasons
Who the study is looking for
- Age: 18 years or older
- Diagnosis: Stroke diagnosis ≤12 months prior to study enrollment
- ≥6 hours of sedentary behavior on a typical weekday (Sedentary Behavior Questionnaire)
- Able to walk 150 feet or more without physical assistance from another person, with or without assistive device (assessed by Functional Independence Measure, mobility score ≥5)
- Able to access an electronic device (smartphone, tablet, or computer) that is compatible with a videoconferencing application
- Able to identify a support person with whom they have a face-to-face interaction at least one time per week.
- Able and willing to participate fully in the study and provide informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| School of Kinesiology, University of Minnesota Coordinator of this site? Confirm its status | Minneapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.